Eleni A. Papadopoulos

Eleni A. Papadopoulos

Auto-generated profile, based on publicly available information

Eleni A. Papadopoulos

Birth Defects Registry, New York State Department of Health, Albany, NY

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2017 in The American Journal on Addictions
Verified
Journal Article
Closed access
PDF file
EPEleni A. Papadopoulos
Eleni A. Papadopoulos
KCKaren R. Cummings
Karen R. Cummings
JMJeanna M. Marraffa
Jeanna M. Marraffa
KAKenneth M. Aldous
Kenneth M. Aldous
LLLingyun Li
Lingyun Li
NANina Ahmad
Nina Ahmad

11 November 2022 in Birth Defects Research
Verified
Journal Article
Open access
KPKristin Palmsten
Kristin Palmsten
JSJonathan Suhl
Jonathan Suhl
KCKristin M. Conway
Kristin M. Conway
EKElyse O. Kharbanda
Elyse O. Kharbanda
TSThomas D. Scholz
Thomas D. Scholz
TSThe National Birth Defects Prevention Study
The National Birth Defects Prevention Study
Background: Although results from studies of first‐trimester influenza vaccination and congenital heart defects (CHDs) have been reassuring, data are limited for specific CHDs.Methods: We assessed associations between reported maternal influenza vaccination, 1 month before pregnancy (B1) through end of third pregnancy month (P3), and specific CHDs using data from a multisite, population‐based case–control study. Analysis included 2,982 case children diagnosed with a simple CHD (no other cardiac involvement with or without extracardiac defects) and 4,937 control children without a birth defect with estimated delivery dates during 2006–2011. For defects with ≥5 exposed case children, we used logistic regression to estimate propensity score‐adjusted odds ratios (aORs) and 95% confidence intervals (CIs), adjusting for estimated delivery year and season; plurality; and maternal age at delivery, race/ethnicity, low folate intake, and smoking and alcohol use during B1P3.Results: Overall, 124 (4.2%) simple CHD case mothers and 197 (4.0%) control mothers reported influenza vaccination from 1 month before through the third pregnancy month. The aOR for any simple CHD was 0.97 (95% CI: 0.76–1.23). Adjusted ORs for specific simple CHDs ranged from 0.62 for hypoplastic left heart syndrome to 2.34 for total anomalous pulmonary venous return (TAPVR). All adjusted CIs included the null except for TAPVR.Conclusions: Although we cannot fully exclude that exposure misclassification may have masked risks for some CHDs, findings add to existing evidence supporting the safety of inactivated influenza vaccination during pregnancy. The TAPVR result may be due to chance, but it may help inform future studies.

19 December 2023 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
EPEleni A. Papadopoulos
Eleni A. Papadopoulos
MHMeredith M. Howley
Meredith M. Howley
SFSarah C. Fisher
Sarah C. Fisher
AZAlissa R. Van Zutphen
Alissa R. Van Zutphen
MWMartha M. Werler
Martha M. Werler
FSfor the National Birth Defects Prevention Study
for the National Birth Defects Prevention Study

27 August 2022 in Environmental Research
Verified
Journal Article
Closed access
YOYanqiu Ou
Yanqiu Ou
EPEleni A. Papadopoulos
Eleni A. Papadopoulos
SFSarah C. Fisher
Sarah C. Fisher
MBMarilyn L. Browne
Marilyn L. Browne
ZLZiqiang Lin
Ziqiang Lin
SLShao Lin
Shao Lin

11 February 2024 in Birth Defects Research
Verified
Journal Article
Closed access
EPEleni A. Papadopoulos
Eleni A. Papadopoulos
MHMeredith M. Howley
Meredith M. Howley
SFSarah C. Fisher
Sarah C. Fisher
AZAlissa R. Van Zutphen
Alissa R. Van Zutphen
MWMartha M. Werler
Martha M. Werler
FSfor the National Birth Defects Prevention Study
for the National Birth Defects Prevention Study

25 July 2026 in Birth Defects Research
Verified
Journal Article
Open access
PDF file
MHMeredith M. Howley
Meredith M. Howley
JSJada M. Scott
Jada M. Scott
EWEva M. Williford
Eva M. Williford
URUma M. Reddy
Uma M. Reddy
EPEleni A. Papadopoulos
Eleni A. Papadopoulos
FEfor the National Birth Defects Prevention Study and Birth Defects Study to Evaluate Pregnancy exposureS
for the National Birth Defects Prevention Study and Birth Defects Study to Evaluate Pregnancy exposureS
Background: Prenatal stress and social support are associated with adverse birth outcomes, including stillbirth, in the general population. Their relationship to stillbirth among fetuses with birth defects is unclear. Using data from the National Birth Defects Prevention Study and the Birth Defects Study To Evaluate Pregnancy exposureS, we examined associations between maternal stress and social support and the risk of stillbirth among fetuses with birth defects and whether these associations differed by maternal race/ethnicity. Methods: Participants self‐reported exposure to stressors and social supports experienced 3 months before conception through the first trimester. Using log‐binomial models, we estimated relative risks (RR) and 95% confidence intervals (CI) of stillbirth associated with high stress and low social support, adjusting for maternal age and race/ethnicity. We assessed additive and multiplicative effect measure modification by maternal race/ethnicity. Results: Neither stress nor social support was associated with stillbirth among fetuses with birth defects. Although we did not observe interaction, we observed increased risk of stillbirth among non‐Hispanic Black women with low stress (RR = 2.1, 95% CI = 1.3–3.6), Hispanic women with low stress (1.4, 1.0–2.1), and non‐Hispanic Black women with high stress (2.8, 1.4–5.2) compared to non‐Hispanic White women with low stress. We observed a similar pattern of results for low social support. Conclusions: Stress and social support were not associated with stillbirth in fetuses with birth defects. We observed elevated risk of stillbirth among non‐Hispanic Black women regardless of stress and social support levels.